Latest News of CYT
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History
By Yahoo! Finance |
3 days ago
Bayer has acquired rights to Cytokinetics' heart drug in Japan through a collaboration deal. The agreement includes an upfront payment of 50 million euros with potential additional payments based on d...
Bayer acquires rights to Cytokinetics' heart drug in Japan
By Yahoo! Finance |
3 days ago
Bayer collaborates with U.S. biotech firm Cytokinetics to acquire rights in Japan for an experimental heart drug, strengthening its cardiovascular business. The deal includes upfront payment of 50 mil...
Here's How Jakafi's Patent Expiry Impacts Incyte Corporation's (INCY) Growth Prospects
By Yahoo! Finance |
5 days ago
Incyte Corporation is preparing for Jakafi's patent expiry in 2028, focusing on growth beyond that period. With innovative therapies and a diverse product pipeline, including Opzelura and other promis...
-
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next
By Yahoo! Finance | 1 week agoVeracyte, Inc. (NASDAQ:VCYT) reported strong quarterly results, beating revenue and earnings estimates. Analysts raised revenue and earnings forecasts, showing optimism in the company's prospects. The...
-
CytomX Therapeutics Inc (CTMX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
By Yahoo! Finance | 2 weeks agoThe CEO, Sean McCarthy, provided updates on CX-904 and CX-2051 programs, emphasizing dose escalation for CX-904 and progress into cohort five for CX-2051. Phase 1B decisions and updates are expected n...
-
MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ...
By Yahoo! Finance | 2 weeks agoMaher Masoud discussed inventory write-down due to product redesign and new engineering head hired for efficient development. Vertex focuses on high-impact workflows and revenue to avoid future losses...
-
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ...
By Yahoo! Finance | 2 weeks agoThe CEO discusses the normalized demand environment in the US, emphasizing the essential role of flow cytometry in biology labs. The CFO expects sequential revenue growth in Q4 and outlines strategies...
-
Should You Consider Investing in Vaxcyte (PCVX)?
By Yahoo! Finance | 2 weeks agoBaron Funds released their Q3 2024 investor letter for the Baron Health Care Fund, reporting a 5.81% appreciation in the quarter. Vaxcyte, Inc. was highlighted as a top pick, with a one-month return o...
-
Incyte Shows Rising Relative Price Performance; Still Shy Of Key Threshold
By Investor's Business Daily | 1 month agoLearn how to scale out of losing stocks by using three signals, including the Relative Strength (RS) Rating from Investor's Business Daily. Top-performing stocks typically have an RS Rating above 80 i...
-
Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
By Yahoo! Finance | 1 month agoA recent article highlights Cytokinetics Inc. as a promising small-cap stock for investment. It discusses the impact of interest rate cuts on small and mid-cap stocks and provides insights from expert...
-
Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and ...
By Yahoo! Finance | 1 month agoThe company achieved GBP 5 million in annualized savings ahead of schedule. Updates include Novacyt's focus on monkeypox assays and completing the Yourgene integration, aiming for growth and new produ...
-
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 2 months agoCytokinetics, Inc. shared positive results from the Phase 1 study of CK-4021586 at a medical conference. The study successfully evaluated safety, tolerability, and pharmacokinetics of CK-586, a drug b...
-
Vaxcyte, Inc. (PCVX): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance | 2 months agoAn article discusses the risks and potential returns associated with investing in biotech stocks, focusing on Vaxcyte, Inc. (NASDAQ:PCVX) and its progress in developing anti-bacterial treatments....
-
Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?
By Yahoo! Finance | 2 months agoA compilation of the 12 Best Biotech Stocks To Invest In According To Hedge Funds includes Cytokinetics, Inc. (NASDAQ:CYTK). The biotech industry is forecasted to grow significantly, with AI-driven dr...
-
Here's Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT)
By Yahoo! Finance | 2 months agoBaron Funds released its Q2 2024 investor letter for the Baron Discovery Fund, highlighting Veracyte, Inc. (NASDAQ:VCYT). The stock showed strong performance with a 38.95% one-month return and a 27% i...